CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-26 | Kulkarni Samarth Chief Executive Officer | Sale | −2,500 | $52.73 | $132K | 312,779 |
| 2022-10-26 | Kulkarni Samarth Chief Executive Officer | Sale | −4,000 | $54.06 | $216K | 308,779 |
| 2022-10-26 | Kulkarni Samarth Chief Executive Officer | Sale | −11,312 | $54.97 | $622K | 297,467 |
| 2022-10-26 | Kulkarni Samarth Chief Executive Officer | Sale | −7,188 | $55.69 | $400K | 290,279 |
| 2022-10-26 | Kulkarni Samarth Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −19,582 | 13,751 | ||
| 2022-10-26 | Kulkarni Samarth Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −5,418 | 254,582 | ||
| 2022-10-17 | Smith Brendan Chief Financial Officer | Shares withheld for taxes | −1,111 | $55.76 | $62K | 2,639 |
| 2022-10-14 | Smith Brendan Chief Financial Officer | Option exercise | +3,750 | 3,750 | ||
| 2022-10-14 | Smith Brendan Chief Financial Officer | Option exercise · Restricted Stock Units | +3,750 | 11,250 | ||
| 2022-10-07 | Smith Brendan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2022-10-07 | Morrow Phuong Khanh Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +9,380 | 9,380 | ||
| 2022-10-07 | KASINGER JAMES R. General Counsel and Secretary | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2022-09-28 | Kulkarni Samarth Chief Executive Officer | Option exercise | +25,000 | $16.21 | $405K | 315,279 |
| 2022-09-28 | Kulkarni Samarth Chief Executive Officer | Sale | −23,200 | $64.58 | $1.5M | 292,079 |
| 2022-09-28 | Kulkarni Samarth Chief Executive Officer | Sale | −1,800 | $64.97 | $117K | 290,279 |
| 2022-09-28 | Kulkarni Samarth Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −25,000 | 33,333 | ||
| 2022-08-29 | Kulkarni Samarth Chief Executive Officer | Option exercise | +25,000 | $16.21 | $405K | 315,279 |
| 2022-08-29 | Kulkarni Samarth Chief Executive Officer | Sale | −4,073 | $66.14 | $269K | 311,206 |
| 2022-08-29 | Kulkarni Samarth Chief Executive Officer | Sale | −20,764 | $66.98 | $1.4M | 290,442 |
| 2022-08-29 | Kulkarni Samarth Chief Executive Officer | Sale | −163 | $67.64 | $11K | 290,279 |
Page 20 of 46 · 910 trades